About: “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by David Tan et al published December 2008 in Journal of Clinical Oncology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2008 (fr) наукова стаття, опублікована в грудні 2008 (uk) im Dezember 2008 veröffentlichter wissenschaftlicher Artikel (de) 2008 ഡിസംബര്‍ 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം (ml) article by David Tan et al published December 2008 in Journal of Clinical Oncology (en)
publication date	wds:Q57694467-EE4770A0-97C8-44A7-98AB-DB0A81B71369
publication date	2008-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57694467-6E92BBC0-881D-4393-9670-B9DB7B7CF026
language of work or name	English
author name string	wds:Q57694467-01E4969C-4660-475B-A5AE-48819F5E8991 wds:Q57694467-3CBD6382-414C-4995-8CEC-80EC9A0BE2ED wds:Q57694467-5D3C83AE-A27A-4773-BD95-CDD1CB84DB18 wds:Q57694467-8075BCEE-4FA8-4822-9CE3-AC6C5F541AD1 wds:Q57694467-8D4031A4-FE17-4FC1-9FA0-8F0CA8735478 wds:Q57694467-C96D9F15-C328-4EB4-96FC-B02900B8BD68 wds:Q57694467-EC28A613-0698-4409-8E2E-BA582B011BCD
author name string	Andrew Norman Elizabeth Bancroft Christian Rothermundt Audrey Ardern-Jones Susan Shanley Martin E. Gore Stanley B. Kaye
rdfs:label	“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (en) “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (nl)
skos:prefLabel	“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (en) “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (nl)
name	“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (en) “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (nl)
author	wds:Q57694467-477F572D-A519-4B49-802B-87E1EA4696C0 wds:Q57694467-76EA43EE-DA49-4A2D-8D73-D6E587380BF0 wds:Q57694467-91DC5E23-1937-4A38-884E-EF77FC8CD9EB
author	Rosalind Eeles David Tan Karen Thomas
title	wds:Q57694467-E05187BE-793F-4A41-BCA0-BB01D35D1B31
title	“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations (en)
page(s)	wds:Q57694467-6E3204DF-B572-48B9-96C3-B464E6F4A47A
page(s)	5530-5536
instance of	wds:Q57694467-8C20BD0F-5749-4869-88E1-DB7335DE6415
instance of	scholarly article
main subject	wds:Q57694467-9BB4F8F4-3807-479B-9C6E-CDF64FC6FEB0 wds:Q57694467-D91C716C-B582-42B7-B2F2-0A59A6E74673
main subject	ovarian neoplasm Patients
PubMed ID	wds:Q57694467-0D014CBF-D816-432B-9378-8A83F4BC7F16
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18955455
PubMed ID	18955455
published in	wds:Q57694467-6682F235-FEAB-4DBB-AFF4-12DB4B0591BD
published in	Journal of Clinical Oncology
issue	wds:Q57694467-F7C80CFD-41C0-4610-9BAC-CA829F82EF54
volume	wds:Q57694467-4E949F1D-E23B-408D-B651-1767BF922FCB
issue	34
volume	26
DOI	wds:Q57694467-A9A07747-F420-4E6F-98F4-EB6E08640865
DOI	http://dx.doi.org/10.1200/JCO.2008.16.1703
DOI	10.1200/JCO.2008.16.1703
skos:altLabel	"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. (en)
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57694467
is cites work of	Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers Management of genetic syndromes predisposing to gynecologic cancers Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence? BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study Prognostic significance of BRCA1 expression in gastric cancer A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Prognostic biomarkers in ovarian cancer The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. A review of PARP inhibitors: from bench to bedside Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2 Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas "Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit? BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer Ovarian cancer: advances in first-line treatment strategies with a particular focus on anti-angiogenic agents. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. Assessment of hepatocyte growth factor in ovarian cancer mortality Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC). Drug therapy for hereditary cancers Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy Recent progress in the diagnosis and treatment of ovarian cancer The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software